With the announcement of Justice Kennedy’s retirement from the US Supreme Court, the Congressional Research Service issued several new and updated reports on the nomination process and related issues.
Justice Kennedy Retires: Initial Considerations for Congress, CRS Legal Sidebar, January 28, 2018
President’s Selection of a Nominee for a Supreme Court Vacancy: Overview, CRS Insight, June 27, 2018
Supreme Court Nomination: CRS Products, CRS Legal Sidebar, June 29, 2018
Other noteworthy CRS products published last week include the following.
Cyber Supply Chain Risk Management: An Introduction, CRS In Focus, June 29, 2018
Global Research and Development Expenditures: Fact Sheet, updated June 27, 2018
U.S. Research and Development Funding and Performance: Fact Sheet, updated June 29, 2018
Trade Deficits and U.S. Trade Policy, June 28, 2018
Organizing Executive Branch Agencies: Who Makes the Call?, CRS Legal Sidebar, June 27, 2018
Efforts to Preserve Economic Benefits of the Iran Nuclear Deal, CRS In Focus, June 27, 2018
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.